EAST.H Stock Overview
A vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
EastWest Bioscience Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.025 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 25.00% |
| 5 Year Change | -28.57% |
| Change since IPO | -85.71% |
Recent News & Updates
Shareholder Returns
| EAST.H | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | 10.1% | 0.2% |
| 1Y | n/a | -19.0% | 21.0% |
Return vs Industry: Insufficient data to determine how EAST.H performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how EAST.H performed against the Canadian Market.
Price Volatility
| EAST.H volatility | |
|---|---|
| EAST.H Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 11.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: EAST.H's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine EAST.H's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Rodney Gelineau | www.eastwestbioscience.com |
EastWest Bioscience Inc., a vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States. The company also operates Sangster’s Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business.
EastWest Bioscience Inc. Fundamentals Summary
| EAST.H fundamental statistics | |
|---|---|
| Market cap | CA$2.52m |
| Earnings (TTM) | CA$108.55k |
| Revenue (TTM) | CA$703.10k |
0.0x
P/E Ratio0.0x
P/S RatioIs EAST.H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EAST.H income statement (TTM) | |
|---|---|
| Revenue | CA$703.10k |
| Cost of Revenue | CA$293.78k |
| Gross Profit | CA$409.33k |
| Other Expenses | CA$300.78k |
| Earnings | CA$108.55k |
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EAST.H perform over the long term?
See historical performance and comparison